Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taizhou Lingfeng Biotechnology is a specialized biotechnology company focused on the development and large-scale manufacturing of high-purity pharmaceutical intermediates and nutraceutical ingredients. The company leverages an advanced technology platform centered on biocatalysis, microbial fermentation, and green chemistry to produce high-value biochemicals such as Pyrroloquinoline Quinone (PQQ), Phosphatidylserine (PS), and Pyridoxal-5'-Phosphate (P5P). Headquartered in Taizhou, China, Lingfeng serves global pharmaceutical, healthcare, and functional food industries by providing high-quality raw materials and comprehensive OEM/ODM solutions. Its research and development capabilities include enzyme engineering (directed evolution) and continuous flow reactions, enabling the production of sustainable and high-purity ingredients for international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lingfeng Biotechnology.